AN EPIDEMIOLOGICAL MODEL OF BREAST CANCER AND PROGRESSION TO BONE METASTASES IN THE UNITED KINGDOM

被引：0
|
作者：
Martin, M. [1 ]
Kearney, M. [2 ]
Bracco, A. [2 ]
Brown, J. [3 ]
机构：
[1] i3 Innovus, Uxbridge, Middx, England
[2] Amgen Europe GmbH, Zug, Switzerland
[3] St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 03期
关键词：
D O I：
10.1016/j.jval.2011.02.877
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A158 / A158
页数：1
相关论文
共 50 条
  • [21] The experiences of men with breast cancer in the United Kingdom
    Iredale, R
    Brain, K
    Williams, B
    France, E
    Gray, J
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (03) : 334 - 341
  • [22] Physicians’ preferences for bone metastases treatments in France, Germany and the United Kingdom
    Yi Qian
    Jorge Arellano
    Francesca Gatta
    Guy Hechmati
    A. Brett Hauber
    Ateesha F. Mohamed
    Amit Bahl
    Roger von Moos
    Jean-Jacques Body
    BMC Health Services Research, 18
  • [23] Costs of breast cancer treatment in the United Kingdom
    Dolan, P
    Torgerson, DJ
    Wolstenholme, J
    BREAST, 1999, 8 (04): : 205 - 207
  • [24] Patients' preferences for bone metastases treatments in France, Germany and the United Kingdom
    Hechmati, Guy
    Hauber, A. Brett
    Arellano, Jorge
    Mohamed, Ateesha F.
    Qian, Yi
    Gatta, Francesca
    Haynes, Ian
    Bahl, Amit
    von Moos, Roger
    Body, Jean-Jacques
    SUPPORTIVE CARE IN CANCER, 2015, 23 (01) : 21 - 28
  • [25] Physicians' preferences for bone metastases treatments in France, Germany and the United Kingdom
    Qian, Yi
    Arellano, Jorge
    Gatta, Francesca
    Hechmati, Guy
    Hauber, A. Brett
    Mohamed, Ateesha F.
    Bahl, Amit
    von Moos, Roger
    Body, Jean-Jacques
    BMC HEALTH SERVICES RESEARCH, 2018, 18
  • [26] Patients' preferences for bone metastases treatments in France, Germany and the United Kingdom
    Hechmati, G.
    Arellano, J.
    Mohamed, A.
    Hauber, B.
    Qian, Y.
    Gatta, F.
    Haynes, I.
    Bahl, A.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S337 - S337
  • [27] STATUS OF BONE SCANNING FOR BONE METASTASES IN BREAST CANCER
    RUBIN, P
    CICCIO, S
    CANCER, 1969, 24 (06) : 1338 - &
  • [28] Expressiveness of Bone Markers in Breast Cancer with Bone Metastases
    Zulauf, Nicole
    Brueggmann, Doerthe
    Groneberg, David
    Oremek, Gerhard Maximilian
    ONCOLOGY, 2019, 97 (04) : 236 - 244
  • [29] Alpharadin inhibits osteoclast differentiation in vitro and progression of established breast cancer bone metastases in vivo
    Suominen, Mari I.
    Rissanen, Jukka P.
    Kakonen, Rami
    Mumberg, Dominik
    Ziegelbauer, Karl
    Halleen, Jussi M.
    Scholz, Arne
    CANCER RESEARCH, 2011, 71
  • [30] Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer
    Boucharaba, A
    Serre, CM
    Grès, S
    Saulnier-Blache, JS
    Bordet, JC
    Guglielmi, J
    Clézardin, P
    Peyruchaud, O
    JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (12): : 1714 - 1725
12345